Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine [4]

Archives of Dermatology

Volumn 141, Issue 1, 2005, Pages 103-104

  Capponi, Angela ^a   De Simone, Clara ^b   Guerriero, Cristina ^b   Rotoli, Maurizio ^b   Bartoloni, Carlo ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BARBEXACLONE; CARBAMAZEPINE; LA ANTIBODY; PHENOBARBITAL; RO ANTIBODY;

ANAMNESIS; BRAIN INJURY; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG USE; GOOD GENERAL CONDITION; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE;

EID: 12444282687     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.1.103     Document Type: Letter

References (5)

1. Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139:45-49.
2. Patel G, Anstey AV. Rifampicin-induced lupus erythematosus. Clin Exp Dermatol. 2001;26:260-262.
3. Brooke R. Terbinafine-induced subacute cutaneous lupus erythematosus [letter]. Br J Dermatol 1998;139:1132-1133.
4. Parodi A, Rivara G, Guarrera M. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. JAMA. 1992;268:51-52.
5. Toepfer M, Sitter T, Lochmuller H, Pongratz D, Muller-Felber W. Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine. Eur J Clin Pharmacol. 1998;54:193-194.